BR112023002591A2 - Processo para a preparação de um composto e composto - Google Patents

Processo para a preparação de um composto e composto

Info

Publication number
BR112023002591A2
BR112023002591A2 BR112023002591A BR112023002591A BR112023002591A2 BR 112023002591 A2 BR112023002591 A2 BR 112023002591A2 BR 112023002591 A BR112023002591 A BR 112023002591A BR 112023002591 A BR112023002591 A BR 112023002591A BR 112023002591 A2 BR112023002591 A2 BR 112023002591A2
Authority
BR
Brazil
Prior art keywords
compound
preparation
atropisomeric
preparing
methods
Prior art date
Application number
BR112023002591A
Other languages
English (en)
Inventor
Lim Ngiap-Kie
Shen Jeff
Trachsel Etienne
Bachmann Stephan
Bigler Raphael
Christoph Meier Roland
Jonathan Orcel Ugo
Elizabeth Sirois Lauren
C Timmerman Jacob
Zhang Haiming
Andrew White Nicholas
Giovanni Dipasquale Antonio
Bradley Pascual Clagg Kyle
Xu Jie
Gosselin Francis
Original Assignee
Genentech Inc
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Hoffmann La Roche filed Critical Genentech Inc
Publication of BR112023002591A2 publication Critical patent/BR112023002591A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

PROCESSO PARA A PREPARAÇÃO DE UM COMPOSTO E COMPOSTO. São fornecidos neste documento métodos para sintetizar compostos de quinazolina compreendendo pelo menos um centro atropisomérico.
BR112023002591A 2020-08-12 2021-08-10 Processo para a preparação de um composto e composto BR112023002591A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063064746P 2020-08-12 2020-08-12
PCT/US2021/045297 WO2022035790A1 (en) 2020-08-12 2021-08-10 Synthesis of quinazoline compounds

Publications (1)

Publication Number Publication Date
BR112023002591A2 true BR112023002591A2 (pt) 2023-04-04

Family

ID=77543703

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023002591A BR112023002591A2 (pt) 2020-08-12 2021-08-10 Processo para a preparação de um composto e composto

Country Status (16)

Country Link
US (1) US20220081413A1 (pt)
EP (1) EP4196470A1 (pt)
JP (1) JP2023537999A (pt)
KR (1) KR20230049679A (pt)
CN (1) CN116057052B (pt)
AR (1) AR123200A1 (pt)
AU (2) AU2021325869C1 (pt)
BR (1) BR112023002591A2 (pt)
CA (1) CA3191001A1 (pt)
CL (1) CL2023000395A1 (pt)
CR (1) CR20230123A (pt)
IL (1) IL300309A (pt)
MX (1) MX2023001682A (pt)
PE (1) PE20230733A1 (pt)
TW (2) TW202423916A (pt)
WO (1) WO2022035790A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116514847A (zh) 2022-01-30 2023-08-01 上海医药集团股份有限公司 一种喹啉类化合物及其应用
TW202342452A (zh) 2022-02-07 2023-11-01 美商建南德克公司 合成喹唑啉化合物之方法
MX2024009593A (es) * 2022-02-07 2024-08-14 Genentech Inc Formas solidas de 1-((s)-4-((r)-7-(6-amino-4-metil-3-(trifluoromet il)piridin-2-il)-6-cloro-8-fluoro-2-(((s)-1-metilpirrolidin-2-il) metoxi)quinazolin-4-il)-3-metilpiperazin-1-il)prop-2-en-1-ona.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010014005A (es) 2008-06-20 2011-02-15 Genentech Inc Compuestos de triazolopiridina inhibidores de jak y los metodos.
US8735409B2 (en) * 2009-12-21 2014-05-27 Qiang Zhang Quinazoline derivatives
JP2013107855A (ja) * 2011-11-22 2013-06-06 Mitsubishi Tanabe Pharma Corp 医薬組成物
EP3055290B1 (en) * 2013-10-10 2019-10-02 Araxes Pharma LLC Inhibitors of kras g12c
US9988357B2 (en) * 2015-12-09 2018-06-05 Araxes Pharma Llc Methods for preparation of quinazoline derivatives
PE20211504A1 (es) * 2018-11-09 2021-08-11 Hoffmann La Roche Compuestos de anillo fusionado

Also Published As

Publication number Publication date
JP2023537999A (ja) 2023-09-06
CN116057052B (zh) 2024-09-03
US20220081413A1 (en) 2022-03-17
IL300309A (en) 2023-04-01
TW202214596A (zh) 2022-04-16
CR20230123A (es) 2023-04-19
MX2023001682A (es) 2023-02-22
CN116057052A (zh) 2023-05-02
AU2021325869A1 (en) 2023-02-23
CA3191001A1 (en) 2022-02-17
CL2023000395A1 (es) 2023-07-28
AU2024200220A1 (en) 2024-02-01
AU2021325869B2 (en) 2024-02-15
KR20230049679A (ko) 2023-04-13
TWI829003B (zh) 2024-01-11
EP4196470A1 (en) 2023-06-21
WO2022035790A1 (en) 2022-02-17
PE20230733A1 (es) 2023-05-03
AR123200A1 (es) 2022-11-09
AU2021325869C1 (en) 2024-05-30
TW202423916A (zh) 2024-06-16

Similar Documents

Publication Publication Date Title
BR112023002591A2 (pt) Processo para a preparação de um composto e composto
CO2021002382A2 (es) Nuevos compuestos heterocíclicos como inhibidores de la monoacilglicerol lipasa
BR112023017763A2 (pt) Inibidores kras g12d
PE20181803A1 (es) Inhibidores de mcl-1 macrociclicos para tratar el cancer
BR112017019287A2 (pt) composto, composição farmaceuticamente aceitável, método de tratamento de câncer, processo para preparar o composto da fórmula i, método para tratar câncer, e kit
BR112023017661A2 (pt) Inibidores de kras
BR112022009390A2 (pt) Síntese melhorada de composto inibidor de kras g12c
BR112022026981A2 (pt) Processos para a preparação de um composto e processo para a síntese de um composto
CL2021001859A1 (es) Inhibidores de la pcsk9 y métodos de uso de los mismos
CL2020002103A1 (es) Anticuerpos anti-htra1 y metodos de uso de los mismos. (divisional solicitud 201801139)
BR112017017349A2 (pt) composto, composição, método para tratar um distúrbio
MA44298B1 (fr) Procédé de production d'un clinker de ciment à basse température
BR112021026899A2 (pt) Compostos heterocíclicos
BR112023023578A2 (pt) Composto, composição farmacêutica compreendendo o composto e método de tratamento de uma leucemia aguda
CL2021001607A1 (es) Anticuerpos anti-pmel17 y conjugados de los mismos
BR112021018733A2 (pt) Composições de d-metirosina e métodos para preparar as mesmas
EA202192840A1 (ru) Способ получения соединений карбамоилоксиметилтриазолциклогексиловой кислоты
CU20220019A7 (es) Proteínas de fusión nkg2d
BR112022001336A2 (pt) Anticorpo biespecífico anti-her2/anti-4-1bb e uso do mesmo
MX2021015301A (es) Métodos de cultivo celular y composiciones para la producción de anticuerpos.
BR112021017710A2 (pt) Composto, composição farmacêutica, método de tratamento
MX2021007511A (es) Procedimiento para la preparacion de anilinas sustituidas.
BR112017017209A2 (pt) processo para inibir incrustação.
CL2023000084A1 (es) Anticuerpos anti-betacelulina, fragmentos de los mismos, y moléculas de unión multiespecíficas
AR111318A1 (es) Proceso para preparar 2-exo-(2-metilbenciloxi)-1-metil-4-isopropil-7-oxabiciclo[2.2.1]heptano